Newsroom

INTERVIEW

CHOSUN BIZ

March 20, 2025

Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods

Read More

INTERVIEW

KBR

March 20, 2025

[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.

Read More

NEWS

March 17, 2025

Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets

Read More

NEWS

September 19, 2024

Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design

Read More

NEWS

August 26, 2024

Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development

Read More

MEDIA

KOREA JOONGANG DAILY

August 26, 2024

Galux to conduct joint research with LG Chem on cancer drug development

Read More